Solventum Corporation logo

Solventum Corporation

TickerSOLVVenueUSSectorHealthcarePrimary listingBeta0.69
$85.60-0.24%
FinScore57

Solventum Corporation is a United States-based company in the Healthcare sector with a market capitalisation of $14.6B. Its FinScore is 57/100; its highest-scoring layer is Momentum (79) and its lowest is Growth (32). The shares trade at 10.2x trailing earnings and are up 9% year to date.

Market cap
$14.6B
P/E (TTM)
10.2x
ROE
29.0%

Share price performance

Loading chart…

About Solventum Corporation

www.solventum.com

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Profile
Sector
Healthcare
Industry
Medical - Instruments & Supplies
HQ
United States
Fiscal year-end
December
Trading currency
USD
Reporting currency
USD
Fundamentals updated
74 days ago
Market
Market cap
$14.6B
Shares outstanding
170.2M
P/E (TTM)
10.2x
Beta (issuer)
0.70
Revenue (latest FY)
$8.3B

Revenue breakdown

FY 2025$8.3B
  • UNITED STATES
    56.1%$4.7B
  • Non-US
    43.9%$3.7B

FinScore

As of 2026-10-19
Overall57
Quality74
Growth32
Value46
Momentum79
Relative Strength63

Snapshot

Ownership

As of 2026-06-30
Institutional
74.0%
Insider
14.8%
Free float
84.7%
Top-5 institutional holders
28.8%
Shares outstanding
170.2M
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for Solventum Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Solventum Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Solventum Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Solventum Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Solventum Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Solventum Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.